Technical Analysis for VCYT - Veracyte, Inc.

Grade Last Price % Change Price Change
grade B 22.415 -14.48% -3.80
VCYT closed up 0.08 percent on Tuesday, October 22, 2019, on 2.26 times normal volume. The price action carved out a bearish shooting star candlestick pattern. That may indicate a downside reversal. Look for price to trade beneath the low of the shooting star for confirmation.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Down
See historical VCYT trend table...

Date Alert Name Type % Chg
Shooting Star Candlestick Bearish -14.48%
Pocket Pivot Bullish Swing Setup -14.48%
Earnings Movers Other -14.48%
Upper Bollinger Band Touch Strength -14.48%
Crossed Above 50 DMA Bullish -14.41%
MACD Bullish Centerline Cross Bullish -14.41%
Expansion Pivot Buy Setup Bullish Swing Setup -14.41%
Pocket Pivot Bullish Swing Setup -14.41%
Stochastic Reached Overbought Strength -14.41%
Overbought Stochastic Strength -14.41%

Older signals for VCYT ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Veracyte, Inc. operates as a diagnostics company in the field of molecular cytology to enhance patient outcomes and lower healthcare costs. It provides Afirma Thyroid FNA Analysis, a solution that consists of its Gene Expression Classifier (GEC), which helps physicians in reducing unnecessary diagnostic surgeries for patients with thyroid nodules. The company is also developing Afirma Malignant GEC test for rare forms of thyroid cancer or metastases to the thyroid that is intended to inform surgical strategy; and idiopathic pulmonary fibrosis and nodules suspicious products for lung cancer. It serves endocrinologists, radiologists, and head and neck specialists. The company was formerly known as Calderome, Inc. and changed its name to Veracyte, Inc. in March 2008. Veracyte, Inc. was incorporated in 2006 and is headquartered in South San Francisco, California.
Organ Systems Gene Expression Lung Cancer Idiopathic Pulmonary Fibrosis Surgeries Glands Thyroid Thyroid Cancer
Is VCYT a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 3 bullish, 0 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicator Value
52 Week High 31.18
52 Week Low 9.2
Average Volume 568,413
200-Day Moving Average 23.8867
50-Day Moving Average 25.118
20-Day Moving Average 24.3795
10-Day Moving Average 25.215
Average True Range 1.2419
ADX 13.16
+DI 31.2237
-DI 16.8111
Chandelier Exit (Long, 3 ATRs ) 24.3243
Chandelier Exit (Short, 3 ATRs ) 25.3257
Upper Bollinger Band 26.5201
Lower Bollinger Band 22.2389
Percent B (%b) 0.93
BandWidth 17.560655
MACD Line 0.161
MACD Signal Line -0.1191
MACD Histogram 0.2801
Fundamentals Value
Market Cap 888.34 Million
Num Shares 33.9 Million
EPS -0.80
Price-to-Earnings (P/E) Ratio -32.76
Price-to-Sales 3.94
Price-to-Book 5.91
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 29.27
Resistance 3 (R3) 29.54 28.80 28.76
Resistance 2 (R2) 28.80 28.02 28.66 28.59
Resistance 1 (R1) 27.50 27.54 27.13 27.23 28.42
Pivot Point 26.76 26.76 26.57 26.62 26.76
Support 1 (S1) 25.46 25.98 25.09 25.19 24.00
Support 2 (S2) 24.72 25.50 24.58 23.83
Support 3 (S3) 23.42 24.72 23.66
Support 4 (S4) 23.15